Cancer is never an easy diagnosis to deal with. There are many different treatment options available that can prove to be quite confusing for both healthcare professionals and their patients. There is also a lengthy approval process that is usually involved when dealing with insurance companies and prospective treatment plans.
However, the Cancer Treatment Centers of America is looking to change all of this with the launch of Clinical Pathways. Clinical Pathways is a revolutionary treatment platform that is designed to help make the process of selecting an appropriate treatment plan simple and easy for both physicians and patients.
As stated in this article, in order to complete the development of Clinical Pathways, Cancer Treatment Centers of America partnered with Allscripts and NantHealth. The platform is automatically updated with all the approved treatment methods for various types of cancer. The data includes side effects, success rate, and other relevant data that can easily be viewed by the treating physician with their patient.
By making all the important information readily accessible within one platform Cancer Treatment Centers of America is hoping to simplify and improve the treatment process. The inclusion of relevant clinical data will also help speed up the approval of claims with prospective insurance companies as well.
The Cancer Centers of America’s main headquarters is located in Boca Raton, Florida. They are a network of five hospitals that treat adult patients who are battling many different types of cancer. Their participating hospitals are located in Atlanta, Chicago, Philadelphia, Phoenix, and Tulsa.
They provide a wide variety of different treatment options ranging from immunotherapy to precision surgical removal. They also work with patients to develop comprehensive post-treatment plans that are designed to help them recover physically and emotionally. With the release of their new platform, they are sure to further improve the experience of their patients during treatment.
For more information on CTCA follow them on Twitter.